PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Clinical trials for PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM explained in plain language.
Never miss a new study
Get alerted when new PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM trials appear
Sign up with your email to follow new studies for PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial offers hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new drug called GV20-0251 for people with advanced solid tumor cancers that have stopped responding to standard treatments. The first part of the study will find a safe dose, and the second part will see how well the drug works against several types of can…
Matched conditions: PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Apr 04, 2026 02:36 UTC
-
Triple-Threat attack on tough colon cancer before surgery
Disease control Recruiting nowThis study is testing if adding two drugs (an immunotherapy called a PD-1 antibody and a drug called bevacizumab) to standard chemotherapy before surgery works better than chemotherapy alone for people with a specific type of locally advanced colon or rectal cancer. The goal is t…
Matched conditions: PMMR/MSS ADENOCARCINOMA OF THE COLON OR RECTUM
Phase: PHASE3 • Sponsor: Jun Huang • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC